These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 741447)

  • 21. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
    Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
    Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of fibrin monomers from human fibrinogen in urea, using soluble or insolubilized thrombin.
    Brosstad F; Godal HC; Kierulf P
    Haemostasis; 1977; 6(4):225-35. PubMed ID: 914081
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinogen Petoskey: identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A.
    Higgins DL; Penner JA; Shafer JA
    Thromb Res; 1981 Sep; 23(6):491-504. PubMed ID: 6459662
    [No Abstract]   [Full Text] [Related]  

  • 24. Qualitative changes in fibrinogen following exposure to agents used for preparation of fibrin monomers.
    Brosstad F; Godal HC
    Haemostasis; 1977; 6(3):149-56. PubMed ID: 18381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the sequence of fibrinopeptide A cleavage from fibrinogen fragment E by thrombin, atroxin, or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Thromb Res; 1993 Jun; 70(6):437-49. PubMed ID: 8362369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different chromatographic behaviour of soluble, non-FSF-stabilized des-AA fibrin/fibrinogen and des-AABB fibrin/fibrinogen complexes.
    Brosstad F
    Thromb Res; 1979; 15(3-4):563-8. PubMed ID: 40318
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.
    Crum ED; Shainoff JR; Graham RC; Ratnoff OD
    J Clin Invest; 1974 May; 53(5):1308-19. PubMed ID: 4856883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen derivatives in plasma.
    Lane DA
    Br J Haematol; 1981 Mar; 47(3):329-35. PubMed ID: 6161635
    [No Abstract]   [Full Text] [Related]  

  • 30. Purification and characterization of a prothrombin activator from the venom of the Australian brown snake, Pseudonaja textilis textilis.
    Masci PP; Whitaker AN; de Jersey J
    Biochem Int; 1988 Nov; 17(5):825-35. PubMed ID: 3075905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coagulation factors and thrombocytes after application of Reptilase in the course of gynecologic operations (author's transl)].
    Cornely M; Barthels M; Henkel E
    Med Klin; 1978 May; 73(20):760-4. PubMed ID: 651762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen to fibrin transformation in umbilical cord blood and purified neonatal fibrinogen.
    Teger-Nilsson AC; Ekelund H
    Thromb Res; 1974 Nov; 5(5):601-12. PubMed ID: 4445984
    [No Abstract]   [Full Text] [Related]  

  • 34. The occurrence and clinical relevance of fibrin fragments in blood.
    Gaffney PJ
    Ann N Y Acad Sci; 1983 Jun; 408():407-23. PubMed ID: 6575697
    [No Abstract]   [Full Text] [Related]  

  • 35. The enhanced activation of Glu-plasminogen by urokinase in the presence of fibrin or des A fibrin as measured by the release of B beta peptide and FDP.
    Urano T; Takada Y; Takada A
    Thromb Res; 1984 Dec; 36(5):429-35. PubMed ID: 6084324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Action on "in vitro" coagulation of Bothrops jararaca and Bothrops atrox snake venoms (reptilase)].
    SANCHEZ FAYOS J; OUTEIRINO J; PANIAGUA G; SERRANO J; MARTINEZ MT
    Rev Clin Esp; 1960 May; 77():215-25. PubMed ID: 14441323
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
    Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
    Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrin aggregation before sol-gel transition.
    Wiltzius P; Dietler G; Känzig W; Hofmann V; Häberli A; Straub PW
    Biophys J; 1982 May; 38(2):123-32. PubMed ID: 7093417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired dysfibrinogenaemia in acute and chronic liver disease.
    Lane DA; Scully MF; Thomas DP; Kakkar VV; Woolf IL; Williams R
    Br J Haematol; 1977 Feb; 35(2):301-8. PubMed ID: 870000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational identity of human fibrinogen and monomeric fibrin.
    Wiltzius P; Hofmann V
    Thromb Res; 1980 Sep; 19(6):793-8. PubMed ID: 7466747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.